Stockreport

Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders' Equity Continued Listing Requirement & Provides Performance Update [Yaho...

Agile Therapeutics, Inc.  (AGRX) 
Last agile therapeutics, inc. earnings: 5/2 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.agiletherapeutics.com/investor-relations
PDF Net Revenue for Full Year 2023 Expected to be in the Range of $20 to $21 Million, an Increase of 84% to 93% Compared to Full Year 2022 GAAP Operating Expenses for Ful [Read more]